Biohaven CFO Buys Massive Option Package, Signals Confidence in Post‑Downturn Turnaround
Biohaven CFO’s 175k‑option buy signals strong insider confidence and potential upside as the company targets FDA approvals, despite a 70% stock decline.
3 minutes to read
